Companies: 10,638     total market cap: โ‚ฌ115.981 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Neurocrine Biosciences
NBIX
#1384
Rank
โ‚ฌ13.10 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
131,45ย โ‚ฌ
Share price
-1.20%
Change (1 day)
7.45%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Revenue for Neurocrine Biosciences (NBIX)

Revenue in 2025 (TTM): โ‚ฌ2.39 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.30 Billion. In 2024 the company made a revenue of โ‚ฌ2.26 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ1.70 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Neurocrine Biosciences from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ2.39 B5.73%
2024 โ‚ฌ2.26 B32.59%
2023 โ‚ฌ1.70 B23%
2022 โ‚ฌ1.38 B38.66%
2021 โ‚ฌ1.00 B17.7%
2020 โ‚ฌ0.85 B20.88%
2019 โ‚ฌ0.70 B78.34%
2018 โ‚ฌ0.39 B192.82%
2017 โ‚ฌ0.13 B844.6%
2016 โ‚ฌ14.26 M-21.13%
2015 โ‚ฌ18.08 M
2014 N/A-100%
2013 โ‚ฌ2.11 M-94.74%
2012 โ‚ฌ40.17 M-32.61%
2011 โ‚ฌ59.61 M136.68%
2010 โ‚ฌ25.18 M1121.97%
2009 โ‚ฌ2.06 M-27.51%
2008 โ‚ฌ2.84 M239.18%
2007 โ‚ฌ0.83 M-97.18%
2006 โ‚ฌ29.73 M-71.57%
2005 โ‚ฌ0.10 B66.56%
2004 โ‚ฌ62.79 M-43.16%
2003 โ‚ฌ0.11 B539.94%
2002 โ‚ฌ17.26 M-63.04%
2001 โ‚ฌ46.69 M201.57%
2000 โ‚ฌ15.48 M-7.3%
1999 โ‚ฌ16.7 M23.9%
1998 โ‚ฌ13.48 M-38.7%
1997 โ‚ฌ21.99 M35.94%
1996 โ‚ฌ16.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Repligen
RGEN
โ‚ฌ0.60 B-73.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚ฌ2.01 B-12.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ50.99 B 2,114.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ51.18 B 2,123.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.88 B 2,240.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.70 B-69.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ0.06 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com